$ETST Dr. Michel Aubé, ETST’s CEO & CSO states,

$ETST Dr. Michel Aubé, ETST’s CEO & CSO states, “ETST CBD-Pharmaceutical Drugs will be designed to treat a variety of things including, but not limited to anxiety, depression, triple negative breast cancer, and fatty liver disease. Together, these diseases and disorders represent a massive market. Mental disorders are increasing worldwide. I look forward into soon discussing further details in regards to the R&D of our Cannabis CBD-Pharmaceutical Drug Pipeline. According to the World Health Organization, between 1990 and 2013 the number of people suffering from depression and/or anxiety increased by nearly 50%. Depression and anxiety disorders cost the global economy US$1 trillion each year. The substantial burden of anxiety-related disorders and the limitations of existing treatments give urgency to developing novel pharmaceutical treatments.”

https://globenewswire.com/news-release/2016/1...nt-IP.html

Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!